Klinische Studien
- A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa (InMed755-201-EB) (PI Prof. Dr. D. Kiritsi)
- A phase I/II, multicenter, randomized, double-blind, placebo within-patient
controlled, first-in-human(FIH) Proof of Concept (PoC) study to evaluate the safety
and efficacy of topically applied SXR1096 cream in patients with Netherton syndrome
(PI Prof. Dr. C. Has) - Erfahrungen mit Rapamycin-Salbe bei Patienten mit Tuberöser Sklerose
- Urorenale Beteiligung bei Epidermolysis bullosa hereditaria (DRKS00025569)